TP53 and urinary bladder carcinoma: In conclusion, our results demonstrated that the anthracycline-induced resistance in tested bladder cancer cells detected by MTS assay and caspase 3/7 activities positively correlated with TP53 mutations in the TMD occurring in mt-p53 J82 and TCCSUP cells.